CV Therapeutics, Inc.

Palo Alto, CA 94304

SBIR Award Summary

Total Number of Awards 1
Total Value of Awards $118K
First Award Date 06/01/00
Most Recent Award Date 06/01/00

Key Personnel

Last Name Name Awards Contact
Belardinelli Luiz Belardinelli 1

1 Award Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 06/01/00 - 11/30/00

Microvascular abnormalities of the retina, such as retinopathy of prematurity, macular degeneration and diabetic retinopathy are among the leading causes of non-traumatic blindness. These diseases are characterized by neovascularization that results from ischemic injury to retinal vessels, i.e., compensatory angiogenesis. In a mouse pup model...